Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
07 March 2014Website:
http://www.neurogene.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 12 min agoDividend
Analysts recommendations
Institutional Ownership
What type of business is Neurogene?
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
What sector is Neurogene in?
Neurogene is in the Healthcare sector
What industry is Neurogene in?
Neurogene is in the Biotechnology industry
What country is Neurogene from?
Neurogene is headquartered in United States
When did Neurogene go public?
Neurogene initial public offering (IPO) was on 07 March 2014
What is Neurogene website?
https://www.neurogene.com
Is Neurogene in the S&P 500?
No, Neurogene is not included in the S&P 500 index
Is Neurogene in the NASDAQ 100?
No, Neurogene is not included in the NASDAQ 100 index
Is Neurogene in the Dow Jones?
No, Neurogene is not included in the Dow Jones index
When does Neurogene report earnings?
The next expected earnings date for Neurogene is 30 August 2024